Latest News

• Smartphone Mindfulness App May Help Curb Loneliness Adults who spend just 20 minutes a day using a smartphone mindfulness training app may feel less lonely and have more social interactions than people who don't, a small experiment suggests.
  Reuters Health Information, March 2019
• EPA Bans Consumer Sales of Methylene Chloride Paint Removers The U.S. Environmental Protection Agency said on Friday it had issued a final rule to prohibit the manufacture, import, processing and distribution of methylene chloride in all paint removers for consumer use.
  Reuters Health Information, March 2019
• Partial Fundoplication May Have Edge in Treating GERD In surgical treatment of gastroesophageal reflux disease (GERD), partial fundoplication (PF) prompts less dysphagia than total fundoplication (TF), according to randomized trial results reported by Scandinavian researchers.
  Reuters Health Information, March 2019
• Long-Term Cancer Survivors at Higher Risk of Hospitalization for Other Diseases Survivors of the 12 most common cancers are at higher risk for a wide range of diseases that require hospitalization and should be monitored for new illnesses during follow-up visits, researchers say.
  Reuters Health Information, March 2019
• Teen Drivers Reaching for Objects More Likely to Crash Teen drivers who wisely stow away their cell phones while they're behind the wheel still need to be aware of another important risk factor for accidents, a small study suggests.
  Reuters Health Information, March 2019
• Sleep Apnea Common in Pregnant Obese Women Undiagnosed, mild obstructive sleep apnea (OSA) is common in late pregnancy among women who are obese, U.S. researchers report.
  Reuters Health Information, March 2019
• User-Friendly Visual-Acuity Chart Shows Good Agreement With Existing Charts The Runge near-vision card is user-friendly and shows good agreement with the Early Treatment Diabetic Retinopathy Study (ETDRS) and Snellen visual-acuity charts, researchers report.
  Reuters Health Information, March 2019
• Common Simple Tests for Dehydration Don't Work for Older Care-Home Residents Looking at someone's eyes, skin, the inside of their mouth, or asking them if they're thirsty, tired, or have a headache, doesn't reveal dehydration in older people living in care homes, according to new research from the U.K.
  Reuters Health Information, March 2019
• New US Reference Standard for Amniotic Fluid Volume A new chart based on observations from more than 1,700 women can serve as a U.S. reference standard for amniotic fluid volume, researchers report.
  Reuters Health Information, March 2019
• Better Lymphoma Outcomes With Bendamustine-Rituximab Combination The combination of bendamustine and rituximab provides better progression-free survival (PFS), event-free survival, and duration of response in patients with indolent non-Hodgkin lymphoma and mantle-cell lymphoma, compared with other regimens, according to five-year results from the BRIGHT follow-up study.
  Reuters Health Information, March 2019
• 'Unworkable' U.S. System Traps Former Sex Slaves With Criminal Records
  Reuters Health Information, March 2019
• Statin Use Tied to Lower Colorectal-Cancer Risk After Negative Colonoscopy Statin use is associated with a reduced risk of colorectal cancer between six and 36 months after an initial negative colonoscopy, according to a retrospective study.
  Reuters Health Information, March 2019
• Pulmonary Fibrosis Foundation Warns Against Stem Cell Infusions The foundation calls for-profit stem cell centers 'the modern-day equivalent of snake oil' and warned against having stem cell treatments except in clinical trials.
  Medscape Medical News, March 2019
• Alert PCSK9 Alirocumab Picks Up New European Indication On the basis of ODYSSEY OUTCOMES results, alirocumab is now approved in Europe to reduce cardiovascular risk in adults with established disease.
  International Approvals, March 2019
• AI Reduces False Positives in Lung Cancer Screening A new machine learning algorithm outperformed existing methods in differentiating benign nodules from cancer.
  Medscape Medical News, March 2019
• TWiST Strengthens PARP Inhibitor Role in Ovarian Cancer New analysis of the NOVA trial confirms clinical benefit from niraparib for patients with recurrent ovarian cancer. The benefit occurred both in patients with and in those without BRCA mutations.
  Medscape Medical News, March 2019
• Alert Ripple Effect: Repackaged Losartan Recalled Due to Impurity Legacy Pharmaceutical recalls 43 repackaged lots of losartan because of the presence of the probable carcinogen N-nitroso-N-methyl-4-aminobutyric acid (NMBA) in the active pharmaceutical ingredient.
  News Alerts, March 2019
• Immunotherapy Should Be First Line in Merkel Cell Carcinoma Pembrolizumab demonstrated durable tumor control, a generally manageable safety profile, and favorable survival outcomes compared with historical data in advanced MCC.
  Medscape Medical News, March 2019
• ENDO 2019From Bench to Bedside: ENDO 2019 Ties Science to Clinical Care 'What distinguishes ENDO from other meetings is that you get a curated view of what is the newest, hottest, and best in science, which you know...is going to be impacting care.'
  Medscape Medical News, March 2019
• Chemo for Early-Stage Prostate Cancer? RTOG 0521 Says Maybe In major clinical trial, docetaxel, which is typically used in metastatic disease, improved outcomes in high-risk, early-stage disease. However, the survival results fell short of the trial target.
  Medscape Medical News, March 2019